OR WAIT null SECS
Check out the latest features and columns!
August's Executive Profile features Marie-France Tschudin, president, innovative medicines international, and chief commercial officer at Novartis
Biopharma experts at the forefront of applying real-world data and real-world evidence across the product life cycle converge to discuss the lingering challenges in fully realizing the vast potential of these insights to transform the value equation
Pharm Exec profiles its 2022 Emerging Pharma Leaders
The windfall from COVID-19 vaccines and treatments has shaken up Pharm Exec’s latest listing of the top global biopharma sales producers in record-breaking fashion
Highlighted Videos
August 18, 2022
There are several strategies life sciences companies can use to benefit from biosimilars.
Raj Verma, chief diversity, culture, and experience officer at Sanofi, discusses the various ways people see diversity around the world and how companies should be building diversity, equity, and inclusion into a company’s everyday fabric.
August 17, 2022
Environmental, social, and governance (ESG) standards are becoming more important for modern investors.
Key traits needed by leaders looking to grow their organizations in the biosimilars market.
August 15, 2022
Pharma loses battle to block price negotiations, but implementation faces many challenges.
All business units will incorporate CSL name and branding to signify one company.
First party validated NPI targeting, clinical data and measurement sets PulsePoint apart from other CTV platforms.
Tilton will bring together Ruder Finn's extensive social and digital capabilities under the healthcare banner and be responsible for the strategic development and execution of digital programs for clients across product, policy, and corporate healthcare communications.
August 12, 2022
Expert naming process valued in fast-tracked approval as drug clears FDA regulatory hurdles.
Multi-year initiative will leverage NFL Alumni events and educational opportunities to raise awareness about effective opioid alternatives.
